ESR1 and breast cancer: Triple-negative breast cancer (TNBC) a special subtype compromising 10–20% of all breast cancers which does not express estrogen receptors (ER), progesterone receptors (PR), or human epidermal growth factor receptor 2 (HER2) [2].